Why does the world have such a 'down' on antidepressants?

Journal of Psychopharmacology

Volumn 22, Issue 3, 2008, Pages 223-226

  Nutt, D J ^a   Malizia, A L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NEFAZODONE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG CONTROL; DRUG DOSE TITRATION; DRUG EFFICACY; EDITORIAL; HUMAN; LICENSING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; PLACEBO EFFECT;

EID: 44949224178     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108091877     Document Type: Editorial

References (16)

1. Anderson, IM, Ferrier, IN, Baldwin, RC, et al. (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (in press).
2. Arana, GW, Nutt, DJ (2007) A critical assessment of methods and processes used to develop psychiatric drug therapeutics. In: Tyrer, P, Silk, K (eds). Effective Treatments in Psychiatry. Cambridge.
3. Bostwick, JM, Pankratz, VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157: 1925-1932.
4. Geddes, J., Carney, S., Davies, C., Furukawa, T., Kupfer, T., Frank, E. (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361: 653-661.
5. Guess, H., Kleinman, A., Kusek, J., Engel, L. (2002) The Science of Placebo: Towards and Interdisciplinary Research Agenda. London: BMJ Books.
6. Isacsson, G. (2000) Suicide prevention - a medical breakthrough ? Acta Psychiatr Scand 102: 113-117.
7. Jacobi, Wittchen (2005) http://ec.europa.eu/health/ph_determinants/ life_style/mental/green_paper/consultation_en.htm.
8. Kirsch, I., Deacon, BJ, Huedo-medina, TB, Scoboria, A., Moore, TJ, Johnson, BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug adminstration. PLoS Med 5: 260-267.
9. Mayberg, HS, Silva, JA, Brannan, SK, Tekell, JL, Mahurin, RK, Jerebek, PA (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159: 728-737.
10. Nutt, DJ (2003) The unhappy saga of 'happy pills'. J Psychopharmacol 17: 251.
11. Nutt, DJ, Sharpe, M. (2008) Uncritical positive regard? Issues in the safety and efficacy of psychotherapy. J Psychopharmacol 22: 3-6.
12. Posternak, MA, Zimmerman, M. (2007) Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis. Br J Psychiatry 190: 287-292.
13. Rhimer, Z., Gonda, X. (2008) Is drug-placebo difference in short term antidepressant drug trials on unipolar major depression much greater than previously believed? J Affect Disord.
14. Scotish Intercollegiate uidelines Netwrok (SIGN) (2003) Secondary prevention of coronary heart disease following myocardial infarction. http://www.sign.ac.uk.
15. Sneed, JR, Rutherford, BR, Rindskopf, D., Lane, DT, Sackeim, HA, Roose, SP (2008) Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 16: 65-73 (Epub 2007 Nov 12).
16. Turner, EH, Rosenthal, R. (2008) Efficacy of antidepressants. BMJ.